Exiqon A/S, a Danish supplier of gene expression analysis products, has disclosed details of its planned acquisition of Oncotech Inc., a privately-held US company that develops and sells diagnostic tests to optimise treatments for cancer patients.
Exiqon A/S, a Danish supplier of gene expression analysis products, has disclosed details of its planned acquisition of Oncotech Inc., a privately-held US company that develops and sells diagnostic tests to optimise treatments for cancer patients.